Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Technology
E-089-2002
Patent ID
E-089-2002-1-US-89
Country
US
Application Type
DIV
Patent Status
Issued
Patent Number
11753627
Publication Number
US-2020-0392469-A1
Application Number
17/009,448
IC
NIAID
Date Filed
Date Issued
Patent PDF
https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11753627
Related Technologies
TAB-671     Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in the 3'-UTR of Dengue Types 1, 2, 3, and 4